758 related articles for article (PubMed ID: 29976103)
1. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
[TBL] [Abstract][Full Text] [Related]
2. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
6. In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins.
Chen W; Zheng M; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2013 Apr; 14(4):1214-22. PubMed ID: 23477570
[TBL] [Abstract][Full Text] [Related]
7. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of aminated poly(glycidyl methacrylate)-based polymers for co-delivery of anticancer drugs and the p53 gene.
Li L; Tian H; He J; Zhang M; Li Z; Ni P
J Mater Chem B; 2020 Oct; 8(41):9555-9565. PubMed ID: 33001126
[TBL] [Abstract][Full Text] [Related]
9. Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review.
Maya S; Sarmento B; Nair A; Rejinold NS; Nair SV; Jayakumar R
Curr Pharm Des; 2013; 19(41):7203-18. PubMed ID: 23489200
[TBL] [Abstract][Full Text] [Related]
10. pH and reduction dual-bioresponsive polymersomes for efficient intracellular protein delivery.
Zhang J; Wu L; Meng F; Wang Z; Deng C; Liu H; Zhong Z
Langmuir; 2012 Jan; 28(4):2056-65. PubMed ID: 22188099
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery.
Yang YQ; Zhao B; Li ZD; Lin WJ; Zhang CY; Guo XD; Wang JF; Zhang LJ
Acta Biomater; 2013 Aug; 9(8):7679-90. PubMed ID: 23669619
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
13. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
[TBL] [Abstract][Full Text] [Related]
14. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers.
Bae HH; Cho MY; Hong JH; Poo H; Sung MH; Lim YT
J Microbiol Biotechnol; 2012 Dec; 22(12):1782-9. PubMed ID: 23221543
[TBL] [Abstract][Full Text] [Related]
15. A novel dual-responsive core-crosslinked magnetic-gold nanogel for triggered drug release.
Ghorbani M; Hamishehkar H; Arsalani N; Entezami AA
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():436-444. PubMed ID: 27524039
[TBL] [Abstract][Full Text] [Related]
16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
17. Temperature/pH/Enzyme Triple-Responsive Cationic Protein/PAA-b-PNIPAAm Nanogels for Controlled Anticancer Drug and Photosensitizer Delivery against Multidrug Resistant Breast Cancer Cells.
Don TM; Lu KY; Lin LJ; Hsu CH; Wu JY; Mi FL
Mol Pharm; 2017 Dec; 14(12):4648-4660. PubMed ID: 29061050
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular Self-Assembled Nanogels a New Platform for Anticancer Drug Delivery.
Varshosaz J; Taymouri S; Ghassami E
Curr Pharm Des; 2017; 23(35):5242-5260. PubMed ID: 28699536
[TBL] [Abstract][Full Text] [Related]
19. Dual-responsive polymersomes as anticancer drug carriers for the co-delivery of doxorubicin and paclitaxel.
Zhou D; Fei Z; Jin L; Zhou P; Li C; Liu X; Zhao C
J Mater Chem B; 2021 Jan; 9(3):801-808. PubMed ID: 33336680
[TBL] [Abstract][Full Text] [Related]
20. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
